NCT06241716

Brief Summary

This prospective randomized controlled trial aims to compare the clinical efficacy and safety of real-time ultrasound guidance (US-RTG) versus static ultrasound-assisted mapping (US-AS) for combined spinal-epidural anesthesia (CSEA) via the paramedian approach in elderly patients aged 60 years and older undergoing orthopedic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 4, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 5, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

February 15, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2025

Completed
Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

1.7 years

First QC Date

January 4, 2024

Last Update Submit

May 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • First-attempt success

    The proportion of the first successful puncture to the total successful puncture

    1 year

Secondary Outcomes (9)

  • Operating time

    1 year

  • Location time

    1 year

  • Depth and width of posterior dural complex (DPEC, WPEC)

    1 year

  • Number of skin punctures

    1 year

  • Number of redirections

    1 year

  • +4 more secondary outcomes

Study Arms (2)

Ultrasound-assisted localization, US-AS

ACTIVE COMPARATOR

Patients in the US-AS group will undergo a pre-procedural ultrasound scan to identify the optimal intervertebral space, measure the depth to the epidural space, and mark the skin entry point and estimated puncture angle. The ultrasound probe will then be removed, and the combined spinal-epidural anesthesia (CSEA) procedure will be performed via the paramedian approach using the pre-marked landmarks.

Procedure: Ultrasound-assisted localization, US-ASProcedure: Real-time ultrasound guidance, US-RTG

Real-time ultrasound guidance, US-RTG

EXPERIMENTAL

Patients in the US-RTG group will undergo CSEA via the paramedian approach under continuous real-time ultrasound visualization. The procedure will be performed using either the in-plane technique in the paracentral transverse plane, allowing direct visualization of needle advancement through the soft tissues and into the epidural and subarachnoid spaces.

Procedure: Ultrasound-assisted localization, US-ASProcedure: Real-time ultrasound guidance, US-RTG

Interventions

In the US-AS group, ultrasonic prescan to determine the best intervertebral space, best puncture Angle and best puncture depth. The optimal puncture section considered by the operator was selected to record the best gap, puncture Angle and depth.

Real-time ultrasound guidance, US-RTGUltrasound-assisted localization, US-AS

In the US-RTG group, the optimal puncture section considered by the operator was selected and recorded directly in the plane of the paracentral transverse section, out of the plane of the paracentral sagittal section or in the plane of the paracentral sagittal section for real-time ultrasound guided lumbar epidural anesthesia.

Real-time ultrasound guidance, US-RTGUltrasound-assisted localization, US-AS

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elderly patients (≥ 60 years old);
  • ASA Grade I to IV.

You may not qualify if:

  • Severe obesity (BMI\>35kg/m2);
  • Spinal deformity or surgical history;
  • Allergic to local anesthetics;
  • There are coagulation disorders;
  • Communication barriers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tianzhu Liu

Wuhan, Hubei, 430000, China

Location

Study Officials

  • Wei Mei, Ph.D.

    Tongji Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 4, 2024

First Posted

February 5, 2024

Study Start

February 15, 2024

Primary Completion

October 20, 2025

Study Completion

October 20, 2025

Last Updated

May 7, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations